BT25 MSDS PDF
BT25 MSDS PDF
BT25 MSDS PDF
The main regional centres are listed here in Section 1. Other local contact numbers for specific language
support in Asia Pacific are listed in Section 16.
Additional information
There are no additional ingredients present which, within the current knowledge of the supplier and in the
concentrations applicable, are classified as hazardous to health or the environment, are PBTs or vPvBs or have been
assigned a workplace exposure limit and hence require reporting in this section.
Type
[1] Substance classified with a health or environmental hazard
[2] Substance with a workplace exposure limit
[3] Substance meets the criteria for PBT according to Regulation (EC) No. 1907/2006, Annex XIII
[4] Substance meets the criteria for vPvB according to Regulation (EC) No. 1907/2006, Annex XIII
[5] Substance of equivalent concern
Occupational exposure limits, if available, are listed in Section 8.
Our REACH (pre-) registrations DO NOT cover the following:
1. The manufacture of these products by our company outside the EU unless covered by the Only Representative provisions, and
2. The importation of these products into Europe by other companies. Re-importation by other companies is not covered by our (pre-) registrations
Customers and other third parties importing and/or re-importing our products into Europe will need either:
- Their own (pre-) registration for substances contained in the imported product, or constituent monomers (imported above 1 tonne per year and >2%
by weight) in the case of imported polymers, or
- In the case of importation only, to make use of the "Only Representative" provisions, if available.
4.2 Most important symptoms and effects, both acute and delayed
Potential acute health effects
Eye contact : Causes serious eye irritation.
Inhalation : Can cause central nervous system (CNS) depression. May cause drowsiness or
dizziness.
Skin contact : Causes skin irritation.
Ingestion : Can cause central nervous system (CNS) depression. May be fatal if swallowed
and enters airways.
Over-exposure signs/symptoms
Eye contact : Adverse symptoms may include the following:
pain or irritation
watering
redness
Inhalation : Adverse symptoms may include the following:
nausea or vomiting
headache
drowsiness/fatigue
dizziness/vertigo
unconsciousness
Skin contact : Adverse symptoms may include the following:
irritation
redness
Ingestion : Adverse symptoms may include the following:
nausea or vomiting
4.3 Indication of any immediate medical attention and special treatment needed
Notes to physician : In case of inhalation of decomposition products in a fire, symptoms may be delayed.
The exposed person may need to be kept under medical surveillance for 48 hours.
Specific treatments : No specific treatment.
6.2 Environmental : Avoid dispersal of spilt material and runoff and contact with soil, waterways, drains
precautions and sewers. Inform the relevant authorities if the product has caused environmental
pollution (sewers, waterways, soil or air). Water polluting material. May be harmful
to the environment if released in large quantities. Collect spillage.
10.3 Possibility of : Under normal conditions of storage and use, hazardous reactions will not occur.
hazardous reactions
10.6 Hazardous : Under normal conditions of storage and use, hazardous decomposition products
decomposition products should not be produced.
Delayed and immediate effects as well as chronic effects from short and long-term exposure
Short term exposure
Potential immediate : Not available.
effects
Potential delayed effects : Not available.
Long term exposure
Potential immediate : Not available.
effects
Potential delayed effects : Not available.
Additional information This product is not This product is not This product is not
regulated as a regulated as a regulated as a
dangerous good when dangerous good when dangerous good when
transported in sizes of transported in sizes of transported in sizes of
≤5 L or ≤5 kg, ≤5 L or ≤5 kg, ≤5 L or ≤5 kg,
provided the provided the provided the
packagings meet the packagings meet the packagings meet the
general provisions of general provisions of general provisions of
4.1.1.1, 4.1.1.2 and 4. 4.1.1.1, 4.1.1.2 and 4. 4.1.1.1, 4.1.1.2 and 4.
1.1.4 to 4.1.1.8. 1.1.4 to 4.1.1.8. 1.1.4 to 4.1.1.8.
Special provisions
274, 335, 601, 375
14.6 Special
precautions for user
International lists
Australia inventory (AICS) : All components are listed or exempted.
15.2 Chemical safety : This product contains substances for which Chemical Safety Assessments are still
assessment required.